# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Calamity Jane (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI008-SYN-TD
- Date: 1901-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ruth Ann Kessler, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- She wants to stop drinking before it kills her, and does not want a lecture **S**
- She is afraid of the shakes if she stops, and has nowhere steady to stay **S**
- She is worried about her liver and her weight **S**

## Your goals

- Finish withdrawal safely at home without a seizure or delirium. Target: 1901-03-09. Recorded outcome: Five days of gabapentin with daily nurse checks; CIWA-Ar 9 at intake, 10 at most, 2 at one week; no seizure, hallucinations or confusion. **S**
- No drinking, her goal, with a medicine for alcohol use disorder. Target: 1901-06-22. Recorded outcome: No alcohol for twelve weeks, then two days of drinking in late May, followed by three weeks without; PEth 820 to 24, then 64 after the lapse. **S**
- Liver tests back to normal and a clear answer on liver scarring. Target: 1901-06-22. Recorded outcome: AST 96 to 31 and ALT 44 to 24 U/L; liver stiffness 9.6 to 6.8 kPa; no advanced fibrosis. **S**
- Regular meals and a healthier weight. Target: 1901-06-22. Recorded outcome: Weight 50.0 to 52.6 kg (BMI 18.4 to 19.3); SNAP benefits and two meals a day on most days. **S**
- A room of her own and health coverage. Target: 1901-06-22. Recorded outcome: Medicaid approved by the four-week visit; a rented room through a housing program by the ten-week visit. **S**
- PHQ-9 below 10, and reassessment once she has stopped drinking. Target: 1901-05-11. Recorded outcome: PHQ-9 14 to 5 after ten weeks without alcohol. **S**

## What we agreed to do

- A nonjudgmental, trauma-informed assessment: AUDIT, DSM-5-TR criteria and PEth explained as part of care, person-first language, a female clinician and a chaperone offered, consent asked before each part of the examination, and her own goals and choices first. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Addiction medicine consultation to confirm the diagnosis, review withdrawal and choose a medicine for alcohol use disorder. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020) **S**
- Outpatient withdrawal management at low risk (PAWSS 3, CIWA-Ar 9): a five-day gabapentin schedule, daily nurse checks with the CIWA-Ar in person or by the clinic phone, her friend as support, fluids and food; hospital care at once for a CIWA-Ar of 15 or more, a seizure, hallucinations, confusion or vomiting. Guideline: The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020) **S**
- Thiamine 100 mg by injection for three days, then by mouth, with folic acid, potassium and magnesium replacement. Guideline: The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020); Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases (2019) **S**
- Medicine for alcohol use disorder: naltrexone 50 mg daily, with a monthly extended-release naltrexone injection if daily tablets are hard to keep; liver tests rechecked on treatment; acamprosate if naltrexone cannot be used; disulfiram not used; a wallet card explaining that naltrexone blocks opioid pain medicines. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026) **S**
- Liver: FIB-4 of 3.93, so transient elastography; liver enzymes, albumin, INR and platelets followed; hepatitis A and B vaccination; acetaminophen no more than 2 g a day. Guideline: Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases (2019) **S**
- Mood and safety: PHQ-9 and GAD-7 again after two to four weeks without alcohol before deciding on depression treatment; a structured safety assessment, a written safety plan, the rifle stored with her friend, the 988 Suicide & Crisis Lifeline, and safety review at every visit. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Recovery support and harm reduction: weekly contact with the clinic's peer recovery support specialist, her choice of mutual-help meetings (Alcoholics Anonymous, SMART Recovery or Women for Sobriety), and a plan for a return to drinking: call the peer specialist or the clinic, eat, do not drink alone or drive, keep taking any medicine for alcohol use disorder, and come back without shame. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026) **S**
- Housing, food, income and coverage: the clinic's community health worker helps with a Montana Medicaid application, SNAP benefits, a food bank, the local Human Resource Development Council's housing programs, Montana 211, and a free phone through the Lifeline program. Guideline: The Healthcare Professional's Core Resource on Alcohol (2026) **S**
- Alcohol and women's health: why the same amount of alcohol does women more harm (higher blood alcohol, faster liver damage, a higher breast cancer risk), a pregnancy test, contraception if needed, and breast and cervical cancer screening at the preventive visit. Guideline: The Healthcare Professional's Core Resource on Alcohol (2026) **S**
- Chewing tobacco: advice to stop and nicotine replacement offered whenever she is ready. Guideline: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**

## Follow-up

- 1901-03-02: Establishing primary care for heavy daily drinking: a nonjudgmental, trauma-informed assessment, withdrawal risk and outpatient withdrawal management, thiamine, liver tests, nutrition, mood and safety, and housing, food and income **S**
- 1901-03-09: One-week review, seen the same day by addiction medicine: after withdrawal, a medicine for alcohol use disorder, the liver plan and recovery supports **S**
- 1901-03-30: Four-week review: naltrexone and the change to a monthly injection, liver stiffness, mood after four weeks without alcohol, and benefits **S**
- 1901-04-27: Periodic adult preventive visit **S**
- 1901-05-11: Ten-week review: recovery, mood, housing and results **S**
- 1901-06-22: Sixteen-week review after a two-day return to drinking: liver tests, PEth, elastography and the plan ahead **S**

This teaching document does not replace care from a qualified clinician.
